Company Filing History:
2 out of 31 
1 out of 29 
Years Active: 2007-2008
Title: Christine Piossek: Innovator in Molecular Biology and Immunology
Introduction
Christine Piossek, located in Winterthur, Switzerland, is an accomplished inventor with a focus on advancements in molecular biology, virology, immunology, and medicine. She holds two patents that reflect her commitment to developing innovative solutions for critical health challenges.
Latest Patents
Her latest invention, the Molecular Antigen Array, is a groundbreaking development in the production of vaccines. This invention provides a composition comprising an ordered and repetitive array of antigens or antigenic determinants. The technology not only outlines a process for producing these biological entities but also emphasizes their potential applications in combating infectious diseases, treating allergies, and even serving as a pharmaccine to prevent or cure cancer. The ordered arrays can efficiently induce self-specific immune responses, particularly antibody responses, thereby marking a significant leap forward in vaccine technology.
Career Highlights
Christine has an impressive career with notable contributions to the field, having worked with leading biotechnology companies such as Cytos Biotechnology and Novartis Pharma. Her expertise in the industry has allowed her to pursue significant innovations that address pressing medical needs.
Collaborations
Throughout her career, Christine has collaborated with esteemed colleagues, including Wolfgang Andreas Renner and Martin F Bachmann. These partnerships have undoubtedly played a role in enhancing her contributions to the realms of molecular biology and immunology, fostering an environment of shared knowledge and innovation.
Conclusion
Christine Piossek stands out as a prominent figure in the landscape of molecular biology and immunology. Her patents, particularly in the area of molecular antigen arrays, underscore her dedication to pioneering advancements that could have far-reaching implications in vaccine development and health care. As she continues to push the boundaries of innovation, her work will hold immense potential for improving global health outcomes.